company background image
TSVT

2seventy bio NasdaqGS:TSVT Stock Report

Last Price

US$14.45

Market Cap

US$547.9m

7D

-5.4%

1Y

-53.3%

Updated

08 Dec, 2022

Data

Company Financials +
TSVT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

TSVT Stock Overview

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.

2seventy bio, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for 2seventy bio
Historical stock prices
Current Share PriceUS$14.45
52 Week HighUS$34.00
52 Week LowUS$9.91
Beta0
1 Month Change-10.91%
3 Month Change-9.74%
1 Year Change-53.31%
3 Year Changen/a
5 Year Changen/a
Change since IPO4.94%

Recent News & Updates

We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Oct 04
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

2seventy Bio: This Spinoff In The CAR-T Space Is Attractive

Sep 08

Recent updates

We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Oct 04
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Aug 12
Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Shareholder Returns

TSVTUS BiotechsUS Market
7D-5.4%0.5%-2.8%
1Y-53.3%-8.6%-19.6%

Return vs Industry: TSVT underperformed the US Biotechs industry which returned -11.2% over the past year.

Return vs Market: TSVT underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is TSVT's price volatile compared to industry and market?
TSVT volatility
TSVT Average Weekly Movement9.6%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: TSVT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: TSVT's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021437Nick Leschlyhttps://www.2seventybio.com

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company.

2seventy bio, Inc. Fundamentals Summary

How do 2seventy bio's earnings and revenue compare to its market cap?
TSVT fundamental statistics
Market CapUS$547.90m
Earnings (TTM)-US$291.99m
Revenue (TTM)US$51.35m

10.7x

P/S Ratio

-1.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TSVT income statement (TTM)
RevenueUS$51.35m
Cost of RevenueUS$278.43m
Gross Profit-US$227.08m
Other ExpensesUS$64.91m
Earnings-US$291.99m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-7.70
Gross Margin-442.19%
Net Profit Margin-568.59%
Debt/Equity Ratio0%

How did TSVT perform over the long term?

See historical performance and comparison